What amount sold does CONSANO BIOLOGICS, LLC report in Form D filings?

The latest linked filings report $59.6M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CONSANO BIOLOGICS, LLC's most recent SEC filing?

CONSANO BIOLOGICS, LLC's most recent Form D filing was on 2026-03-20.

How many investors does CONSANO BIOLOGICS, LLC have?

The most recent Form D filing lists 28 investor(s).

What type of securities does CONSANO BIOLOGICS, LLC offer?

CONSANO BIOLOGICS, LLC's SEC Form D filings indicate equity offerings.

CONSANO BIOLOGICS, LLC

CIK: 0001981285·Biotechnology·BURLINGTON, MA·Corporation·Founded 2024

Reported Sold

$59,564,466

Total Filings

Identified Offerings

Last Filed

Mar 20, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 20, 2026Form D — New notice

Reported sold: $34,824,466 · Target: $48,858,795

Rule 506(b)·28 investors

Dec 12, 2025Form D — New notice

Reported sold: $16,840,000 · Target: $16,840,000

Rule 506(b)·18 investors

Jun 13, 2023Form D — New notice

Reported sold: $7,900,000 · Target: $12,000,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$59,564,466

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jerome Adams

Director

Appears on 2 filings

Doug Vander Weide

Director

Appears on 2 filings

Jennifer Schmitke

Executive Officer

Appears on 2 filings

Bill Abbington

Director

Appears on 2 filings

Andrew Hall

Executive Officer, Director

Appears on 2 filings

John Conway

Related Person

Appears on 1 filing

REGENEXX HOLDINGS, LLC

Related Person

Appears on 1 filing

WAYNE SCHELLHAMMER

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 20, 2026	New	$48,858,795	$34,824,466	28
Dec 12, 2025	New	$16,840,000	$16,840,000	18
Jun 13, 2023	New	$12,000,000	$7,900,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Typewriter Therapeutics, Inc.

Biotechnology

Offering target: $56,299,999

Filed Sep 21, 2026